Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
Odell Fellow in the Natural Sciences at Christ's College Cambridge, University Reader in the Natural Sciences and Curator of Fossil Vertebrates at the Sedgwick Museum of Earth Sciences. Chairman of the Charles Darwin & Galapagos Islands Trust Fund. Associate Editor (and former Editor) of the Zoological Journal of the Linnean Society of London. Council Member of the Cambridge Philosophical Society.
Professor of Chemical & Biological Engineering at the University of Wisconsin - Madison.
An engineer by training with a wide interest in low speed aerodynamics and the fluid dynamics of animal locomotion. PhD topic was the flight of the large pterosaurs. Research Associate at the universities of Bristol and Southampton in the UK.
Tenured Scientist (Associate Professor) at Institute of Catalysis - The Spanish National Research Council (CSIC). Fellow of the RSC. Membership of AAAS, Program Excellence in Science in 2005.
Dr. Tarl Prow is the Deputy Director of the Dermatology Research Centre within the School of Medicine and heads a group of 10 researchers focused on micromedical devices for dermatology and nanomedicine. He is a multidisciplinary researcher with internationally recognized expertise in the fields of micro-medical device development, nanodermatology, topical drug delivery and non-invasive imaging.
Prof Thomas Ritter, leader of research programme, was recruited by the National University of Ireland, Galway as a lecturer in Gene Therapy and Regenerative Medicine and assumed his position in March 2005. Prof. Ritter has over 20 year experience in the field of gene therapy in organ transplantation. He obtained his Ph.D. degree in 1994 from the Max-Planck Research group of Immunology / Rheumatology at the University of Erlangen-Nuremberg, Germany where he worked on the molecular characterization of T cell receptors specific for human collagen type II. Having completed his Post-Doctoral Fellowship at Marseille, Center of Immunology in 1995, Prof. Ritter took up a faculty position at the prestigious Charité University Hospital in Berlin, Germany. He worked as a leader of the gene therapy programme in experimental transplantation in the Institute of Medical Immunology under the directorship of Prof. Dr. H.-D. Volk. His research focused on the development of efficient viral gene-transfer systems for application in transplantation medicine. Prof. Ritter was successful in obtaining funding from the German Research Foundation and the Ministry of Health and Research as well as from industry (Schering). Prof. Ritter completed his 'Habilitation' (postdoctoral lecture qualification) in Immunology in 2002 followed by a promotion to assistant professor in 2003.
Besides current research activities in pre-treatment and biochemical conversion of lignocellulose Rova has a background in recombinant protein expression, protein crystallization, biochemical characterization of catalytical properties of enzymes.
Professor at UC Berkeley since 1980. Resides in the Department of Mechanical Engineering. Research in biomedical engineering.
Research interests: cell proliferation, breast and prostate cancer, endocrine disruptors. In collaboration with Dr. Sonnenschein she proposed the tissue organization field theory, which posits that cancer is a problem of tissue organization and that the default state of metazoan cells, like that of unicellular organisms, is proliferation. She also works on the clarification of epistemological issues arising from the study of complex biological phenomena.
Assistant Professor, Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Principal Investigator of Chemical Biology Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences; Council Member of Asian Pacific Society for Neurochemistry. Recipient of CAS Pioneer Hundred Talents Program, Migraine Research Foundation Award,Chinese Pharmaceutical Association (CPA)-Sanofi Award for Young Scientists in Bio-medicine, ISN -CAEN Award, APSN Young Investigator Award, ISN-ESN Young Investigator Award.